BBS Bioactive (Finland) Probability of Future Stock Price Finishing Over 27.68
| BONEH Stock | EUR 0.07 0 1.47% |
BBS |
BBS Bioactive Target Price Odds to finish over 27.68
The tendency of BBS Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 27.68 or more in 90 days |
| 0.07 | 90 days | 27.68 | close to zero percent |
Based on a normal probability distribution, the odds of BBS Bioactive to move over € 27.68 or more in 90 days from now is close to zero percent (This BBS Bioactive Bone Substitutes probability density function shows the probability of BBS Stock to fall within a particular range of prices over 90 days) . Probability of BBS Bioactive Bone price to stay between its current price of € 0.07 and € 27.68 at the end of the 90-day period is about 92.07 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 1.46 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, BBS Bioactive will likely underperform. Additionally BBS Bioactive Bone Substitutes has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. BBS Bioactive Price Density |
| Price |
Predictive Modules for BBS Bioactive
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BBS Bioactive Bone. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BBS Bioactive Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. BBS Bioactive is not an exception. The market had few large corrections towards the BBS Bioactive's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BBS Bioactive Bone Substitutes, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BBS Bioactive within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.85 | |
β | Beta against Dow Jones | 1.46 | |
σ | Overall volatility | 0.10 | |
Ir | Information ratio | -0.2 |
BBS Bioactive Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BBS Bioactive for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BBS Bioactive Bone can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BBS Bioactive Bone generated a negative expected return over the last 90 days | |
| BBS Bioactive Bone has high historical volatility and very poor performance | |
| BBS Bioactive Bone has some characteristics of a very speculative penny stock | |
| BBS Bioactive Bone has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (2.77 M) with loss before overhead, payroll, taxes, and interest of (56.95 K). | |
| BBS Bioactive Bone Substitutes has accumulated about 3.44 M in cash with (2.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 46.0% of the company shares are held by company insiders |
BBS Bioactive Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BBS Stock often depends not only on the future outlook of the current and potential BBS Bioactive's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BBS Bioactive's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.6 M | |
| Short Long Term Debt | 1.1 M | |
| Shares Float | 6.8 M |
BBS Bioactive Technical Analysis
BBS Bioactive's future price can be derived by breaking down and analyzing its technical indicators over time. BBS Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BBS Bioactive Bone Substitutes. In general, you should focus on analyzing BBS Stock price patterns and their correlations with different microeconomic environments and drivers.
BBS Bioactive Predictive Forecast Models
BBS Bioactive's time-series forecasting models is one of many BBS Bioactive's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BBS Bioactive's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about BBS Bioactive Bone
Checking the ongoing alerts about BBS Bioactive for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BBS Bioactive Bone help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| BBS Bioactive Bone generated a negative expected return over the last 90 days | |
| BBS Bioactive Bone has high historical volatility and very poor performance | |
| BBS Bioactive Bone has some characteristics of a very speculative penny stock | |
| BBS Bioactive Bone has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (2.77 M) with loss before overhead, payroll, taxes, and interest of (56.95 K). | |
| BBS Bioactive Bone Substitutes has accumulated about 3.44 M in cash with (2.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 46.0% of the company shares are held by company insiders |
Other Information on Investing in BBS Stock
BBS Bioactive financial ratios help investors to determine whether BBS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BBS with respect to the benefits of owning BBS Bioactive security.